US Stock MarketDetailed Quotes
BNOX Bionomics
- 0.300
- +0.002+0.70%
Close Nov 29 13:00 ET
- 0.300
- 0.000-0.03%
Post 16:58 ET
5.86MMarket Cap-234P/E (TTM)
0.318High0.287Low270.34KVolume0.290Open0.298Pre Close80.32KTurnover1.62%Turnover RatioLossP/E (Static)19.53MShares1.60052wk High0.34P/B5.02MFloat Cap0.17752wk Low--Dividend TTM16.73MShs Float22.000Historical High--Div YieldTTM10.30%Amplitude0.177Historical Low0.297Avg Price1Lot Size
Bionomics Key Stats
Quarterly+Annual
YOY
| (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -0.07%-4.43M | -0.29%-14.68M | -4.43M | 2.19%-14.64M | -164.22%-14.97M | |||||
| Net income from continuing operations | 85.29%-804.79K | 27.54%-15.49M | ---- | ---5.47M | -42.84%-21.38M | ---- | ---- | ---- | ---- | -129.07%-14.97M |
| Operating gains losses | -4,160.07%-2.73M | 34.21%-366.33K | ---- | --67.32K | -209.34%-556.78K | ---- | ---- | ---- | ---- | 164.75%509.22K |
| Depreciation and amortization | -0.12%165.71K | -0.03%662.99K | ---- | --165.91K | -13.10%663.19K | ---- | ---- | ---- | ---- | -40.28%763.17K |
| Other non cash items | -30.89%111.08K | -347.96%-1.75M | ---- | --160.72K | 11.05%707.75K | ---- | ---- | ---- | ---- | 134.80%637.34K |
| Change In working capital | -332.25%-1.2M | -68.27%1.45M | ---- | --516.08K | 218.97%4.58M | ---- | ---- | ---- | ---- | -414.04%-3.85M |
| -Change in receivables | 167.22%10.92K | -92.77%299.2K | ---- | ---16.25K | 203.14%4.14M | ---- | ---- | ---- | ---- | -363.56%-4.01M |
| -Change in prepaid assets | -46.72%227.66K | 94.69%338.71K | ---- | --427.32K | --173.98K | ---- | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | -830.80%-1.29M | 111.27%1.08M | ---- | --175.87K | -24.01%512.26K | ---- | ---- | ---- | ---- | 1,517.23%674.08K |
| -Change in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -541.71%-412.94K |
| -Change in other current liabilities | 45.32%-19.72K | -26.41%-126.11K | ---- | ---36.06K | ---99.77K | ---- | ---- | ---- | ---- | ---- |
| -Change in other working capital | -280.01%-132.22K | 0.00%-139.17K | ---- | ---34.79K | -34.21%-139.17K | ---- | ---- | ---- | ---- | 43.28%-103.7K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -0.07%-4.43M | -0.29%-14.68M | ---- | ---4.43M | 2.19%-14.64M | ---- | ---- | ---- | ---- | -164.22%-14.97M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -59.34%130.01K | 0 | 809.70%427.68K | ||||||
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | 365.07%119.38K |
| Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | 436.69%299.68K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | ---- | ---- | ---- | --0 | -59.34%130.01K | --0 | 809.70%427.68K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -137.11%-227.34K | 291.58%15.11M | 70.12%6.93M | 2,512.98%612.54K | -79.22%3.86M | 13.16K | -107.04%-205.49K | -78.18%4.08M | 97.07%-25.39K | -21.67%18.57M |
| Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | -53.12%-26.86K | -4.44%-28.41K | 42.94%-25.39K | 98.66%-119.85K |
| Net common stock issuance | --0 | 162.07%10.11M | -76.15%1.2M | --6.26M | -82.95%3.86M | ---- | ---- | -75.69%5.05M | --0 | -31.30%22.63M |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Proceeds from stock option exercised by employees | --409 | --5M | ---- | --0 | --0 | ---- | --0 | ---- | --0 | ---- |
| Net other financing activities | 95.97%-227.75K | ---- | --5.01M | ---5.65M | ---- | ---- | 28.47%-178.63K | ---- | ---- | -1,160.64%-3.94M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -137.11%-227.34K | 291.58%15.11M | 70.12%6.93M | 2,512.98%612.54K | -79.22%3.86M | --13.16K | -107.04%-205.49K | -78.18%4.08M | 97.07%-25.39K | -21.67%18.57M |
| Net cash flow | ||||||||||
| Beginning cash position | 4.15%12.69M | -47.50%12.18M | -59.86%8.21M | -44.24%12.18M | 18.36%23.21M | --15.08M | -31.87%20.62M | 28.58%20.46M | 6.83%21.85M | 470.01%19.61M |
| Current changes in cash | -22.09%-4.66M | 103.97%428.02K | 839.42%1.76M | -78.74%-3.82M | -367.32%-10.78M | ---3.29M | -3,152.48%-5.54M | -98.61%187.62K | 52.79%-2.14M | -77.58%4.03M |
| Effect of exchange rate changes | 190.57%138.37K | 131.57%76.97K | 86.91%-98.03K | -120.46%-152.77K | 55.50%-243.82K | ---241.06K | 99.91%-671.5376 | -117.37%-748.67K | 4,623.42%746.58K | -5,477.45%-547.87K |
| End cash Position | -0.57%8.16M | 4.15%12.69M | -51.50%10.13M | -59.86%8.21M | -47.24%12.18M | --12.18M | -49.21%15.08M | -28.60%20.88M | 28.58%20.46M | 7.83%23.09M |
| Free cash flow | -0.07%-4.43M | -0.29%-14.68M | -32.32%-5.32M | -109.92%-4.43M | 2.20%-14.64M | ---3.17M | -95.04%-5.33M | 27.26%-4.02M | 44.21%-2.11M | -164.19%-14.97M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data